Demonstrating effectiveness is at the core of the RCT revolution (led by lab, quasi and discontinuous randomistas and followed by many of us on twitter). It is only quite recently that structural models have begun to appear that allow for reliable estimates for welfare improvements, demand curves and benefit flows. For instance, this recent study on de-worming in Kenya which … [Read more...] about 10 Pitfalls in Cost Benefit Analysis